ERBB2 and breast cancer: In women with EBC receiving neoadjuvant chemotherapy, 25-OH VD level is inversely correlated with the percentage of pathological complete response, a strong prognostic factor, especially in HER2-positive (HER2+) and triple-negative BC [12].